Literature DB >> 3035000

Human medullary thyroid carcinoma in tissue culture; secretion of calcitonin and carcinoembryonic antigen.

R Oosterom, T Verleun, H A Bruining, W H Hackeng, S W Lamberts.   

Abstract

Monolayer cultures of medullary thyroid carcinoma (MTC) cells were prepared from 5 patients with familial and 4 with sporadic MTC. Basal calcitonin (CT) release decreased rapidly during 17 days in culture. Addition of extra calcium (2 mmol/l) or dibutyryl cyclic AMP (dBcAMP, 3 mmol/l) increased CT release in all investigated cultures (p less than 0.01). No significant differences were observed between cell suspensions prepared from familial and those from sporadic MTC. Carcinoembryonic antigen (CEA) was found in 3 out of 5 MTC cell suspensions from patients with familial tumors and in 2 out of 2 sporadic tumors. Only two cultures secreted measurable amounts of CEA, which decreased with culture time but at a much slower rate than that of CT release. CEA release was not affected by the addition of calcium and dBcAMP. This study shows an absent relation between basal and stimulated CT and CEA release by cultured MTC cells.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3035000     DOI: 10.1007/BF03347169

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  15 in total

1.  Calcitonin secretion by monolayer cultures of human C-cells derived from medullary thyroid carcinoma.

Authors:  B A Roos; L L Bundy; E A Miller; L J Deftos
Journal:  Endocrinology       Date:  1975-07       Impact factor: 4.736

2.  Calcitonin and carcinoembryonic antigen as tumor markers in medullary thyroid carcinoma.

Authors:  R A DeLellis; A H Rule; I Spiler; L Nathanson; A H Tashjian; H J Wolfe
Journal:  Am J Clin Pathol       Date:  1978-10       Impact factor: 2.493

3.  Human medullary thyroid carcinoma: control of calcitonin secretion in vivo and in tissue culture.

Authors:  K M Gautvik; A H Tashjian
Journal:  Horm Metab Res       Date:  1974-01       Impact factor: 2.936

4.  Medullary carcinoma of the thyroid gland.

Authors:  W M Keynes; A S Till
Journal:  Q J Med       Date:  1971-07

5.  Evidence of multicentric origin of the multiple endocrine neoplasia syndrome type 2a (Sipple's syndrome) in a large family in the Netherlands. Diagnostic and therapeutic implications.

Authors:  C J Lips; W H Minder; J R Leo; A Alleman; W H Hackeng
Journal:  Am J Med       Date:  1978-04       Impact factor: 4.965

6.  Medullary carcinoma of the thyroid in Norway. Clinical course and endocrinological aspects.

Authors:  T Normann; K M Gautvik; J V Johannessen; I O Brennhovd
Journal:  Acta Endocrinol (Copenh)       Date:  1976-09

7.  Isolation of large numbers of dispersed human pituitary adenoma cells obtained by aspiration.

Authors:  R Oosterom; G Blaauw; R Singh; T Verleun; S W Lamberts
Journal:  J Endocrinol Invest       Date:  1984-08       Impact factor: 4.256

8.  Human medullary carcinoma of the thyroid in tissue culture.

Authors:  Y Kaneko; T Obara; Y Fujimoto
Journal:  Horm Metab Res       Date:  1983-04       Impact factor: 2.936

9.  Identification of carcinoembryonic antigen in the C-cell of the normal thyroid.

Authors:  T Kodama; M Fujino; Y Endo; T Obara; Y Fujimoto; T Oda; T Wada
Journal:  Cancer       Date:  1980-01-01       Impact factor: 6.860

10.  Association of medullary carcinoma of the thyroid with carcinoembryonic antigen.

Authors:  N Ishikawa; S Hamada
Journal:  Br J Cancer       Date:  1976-08       Impact factor: 7.640

View more
  1 in total

1.  The role of combined imaging in metastatic medullary thyroid carcinoma: 111In-DTPA-octreotide and 131I/123I-MIBG as predictors for radionuclide therapy.

Authors:  Zairong Gao; Hans J Biersack; Samer Ezziddin; Timur Logvinski; Rui An
Journal:  J Cancer Res Clin Oncol       Date:  2004-08-05       Impact factor: 4.553

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.